HATCo CEO Steps Down as Summa Health Acquisition Closes
Marc Harrison Steps Down as HATCo CEO, Daryl Tol Promoted Amid General catalyst Acquisition of Summa Health
Table of Contents
Marc Harrison, MD, is transitioning from his role as CEO of Health Assurance Transformation corp.(HATCo) to a strategic advisor, effective July 31. The leadership change coincides wiht General catalyst’s ongoing acquisition of Summa Health, a two-hospital system based in Akron, Ohio.
Leadership Shuffle Signals Strategic Evolution for HATCo and Summa Health
The leadership transition at HATCo marks a important moment as the venture capital firm General Catalyst finalizes its acquisition of Summa Health. Dr. Harrison’s move to a strategic advisor role is seen as a natural progression as HATCo’s strategy evolves to meet its ambitious goals.
Daryl Tol Ascends to President of HATCo
Daryl Tol will be promoted to president of HATCo, with his new role also effective July 31. Tol has been instrumental in leading HATCo’s transformation and integration efforts on the ground in Akron. Previously, he served as president and CEO of AdventHealth’s Central Florida Division.
In his new capacity as president, Tol will continue to spearhead day-to-day collaboration with Summa Health leadership and the General Catalyst/hatco team to ensure a seamless transition. He will also act as a key liaison within the General Catalyst health assurance ecosystem,focusing on merging innovative ideas,processes,and technologies from emerging entrepreneurs and forward-thinking healthcare systems.
harrison’s New Role Focused on Strategic Vision
Molly Gillis, a spokesperson for hatco, stated that the timing is opportune for Dr. Harrison’s transition to an advisory capacity. “The vision for HATCo and our partnership with Summa Health is tremendously ambitious, matched only by the positive impact we intend to make for the future of healthcare,” Gillis said.”as the strategy for hatco has appropriately evolved to meet those ambitions, it became increasingly clear to both Marc and to us that Marc’s role would best be accomplished as a strategic advisor to [General Catalyst CEO] Hemant Taneja as we bring that ambition and vision to life.”
Gillis added that this change will allow Dr. Harrison to contribute his clinical perspective on macro trends within the industry as HATCo enters a crucial phase in its mission to make health assurance a reality for all. “We look forward to leveraging his invaluable perspective as we continue to progress,” she noted.
General Catalyst’s Acquisition of summa health
General catalyst agreed in November 2024 to purchase Summa Health for $485 million. This acquisition is part of a broader plan to transform the health system into a for-profit entity under HATCo. HATCo is targeting the fourth quarter of 2025 to finalize the transaction.
Dr. Harrison previously served as president and CEO of Intermountain Health from 2016 to 2022 before taking on the CEO role at HATCo in 2023.His extensive experience in healthcare leadership is expected to be a valuable asset in his new advisory position.
Kate Walsh to Chair Summa Health Board
Along with the leadership changes at HATCo, former Boston Medical Center CEO Kate Walsh will serve as chairperson of the board for Summa Health post-close of the transaction. Walsh,who recently stepped down as Massachusetts HHS secretary,will also join the HATCo board.
“Kate brings a wealth of knowledge and experience, and we couldn’t be more excited to partner with her on this next evolution for both Summa Health and hatco,” Gillis commented. Walsh’s expertise is anticipated to play a pivotal role in guiding Summa Health through its transformation under new ownership.